Raymond James Financial’s Anterix ATEX Stock Holding History

Raymond James Financial’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-439	Closed	-$11.3K	–	5082
2025 Q2	$11.3K	Buy	+439	New	+$12.8K	﹤0.01%	5877

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

GECH

Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Raymond James Financial's ATEX Position: Q3 2025 in Review

Raymond James Financial sold out of Anterix (ATEX) in Q3 2025, closing a stake of 439 shares — an estimated $11.3K sold.

Raymond James Financial first reported a position in ATEX in Q2 2025 and held it in 1 quarter. The position peaked at $11.3K in Q2 2025. 111 funds tracked by Wall St. Rank hold ATEX as of Q3 2025.

Raymond James Financial reported no remaining Anterix position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 439 Anterix shares in Q3 2025, an estimated $11.3K.
Raymond James Financial first reported a position in Anterix in Q2 2025 and held it in 1 quarter.
Raymond James Financial's Anterix position peaked at $11.3K in Q2 2025.
111 funds tracked by Wall St. Rank held Anterix as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.